Fujigraf 2 Capsule contains Tacrolimus 2mg, an immunosuppressive agent primarily used to prevent organ rejection in patients undergoing kidney, liver, or heart transplantation. Tacrolimus works by inhibiting calcineurin, a protein phosphatase involved in activating T-cells of the immune system, thereby reducing the body's immune response and preventing it from attacking the transplanted organ. Fujigraf 2 Capsule is prescribed to maintain graft survival and improve transplant outcomes. It is essential to take this medication exactly as directed by a healthcare professional, as improper use can lead to serious side effects or transplant rejection. Common side effects may include headache, tremors, gastrointestinal disturbances, increased susceptibility to infections, and elevated blood sugar or blood pressure. Regular monitoring of blood levels, kidney function, and liver function is necessary during treatment to ensure optimal dosing and minimize toxicity. Patients should avoid grapefruit and grapefruit juice while taking Fujigraf 2 Capsule, as these can increase tacrolimus levels and risk of adverse effects. This medication should be used under strict medical supervision, and patients must report any unusual symptoms or signs of infection promptly. Fujigraf 2 Capsule plays a critical role in transplant medicine by helping to preserve organ function and improve patient survival rates.